Aldrete Carlos A, An Connie, Call Connor C, Gao Xiaojing J, Vlahos Alexander E
Department of Chemical Engineering, Stanford University, CA, USA, 94305.
Curr Opin Biomed Eng. 2024 Dec;32. doi: 10.1016/j.cobme.2024.100555. Epub 2024 Aug 14.
Mammalian synthetic biology aims to engineer cellular behaviors for therapeutic applications, such as enhancing immune cell efficacy against cancers or improving cell transplantation outcomes. Programming complex biological functions necessitates an understanding of molecular mechanisms governing cellular responses to stimuli. Traditionally, synthetic biology has focused on transcriptional circuits, but recent advances have led to the development of synthetic protein circuits, leveraging programmable binding, proteolysis, or phosphorylation to modulate protein interactions and cellular functions. These circuits offer advantages including robust performance, rapid functionality, and compact design, making them suitable for cellular engineering or gene therapies. This review outlines the post-translational toolkit, emphasizing synthetic protein components utilizing proteolysis or phosphorylation to program mammalian cell behaviors. Finally, we focus on key differences between rewiring native signaling pathways and creating orthogonal behaviors, alongside a proposed framework for translating synthetic protein circuits from tool development to pre-clinical applications in biomedicine.
哺乳动物合成生物学旨在设计细胞行为用于治疗应用,比如增强免疫细胞对抗癌症的功效或改善细胞移植结果。对复杂生物学功能进行编程需要了解控制细胞对刺激反应的分子机制。传统上,合成生物学专注于转录回路,但最近的进展已促成合成蛋白质回路的发展,利用可编程的结合、蛋白水解或磷酸化来调节蛋白质相互作用和细胞功能。这些回路具有包括强大性能、快速功能性和紧凑设计等优势,使其适用于细胞工程或基因治疗。本综述概述了翻译后工具包,重点介绍利用蛋白水解或磷酸化来编程哺乳动物细胞行为的合成蛋白质组件。最后,我们关注重新连接天然信号通路与创造正交行为之间的关键差异,以及一个将合成蛋白质回路从工具开发转化到生物医学临床前应用的提议框架。